Cas:21889-13-4 2-[[4-(dimethylamino)phenyl]methylidene]indene-1,3-dione manufacturer & supplier

Chemical Name:2-[[4-(dimethylamino)phenyl]methylidene]indene-1,3-dione

CAS.NO:21889-13-4

Synonyms:2-((4-(DIMETHYLAMINO)PHENYL)METHYLENE)INDANE-1,3-DIONE;2-(4-dimethylaminophenylmethylene)-1H-indane-1,3-dione;4-(N,N-dimethylamino)benzylidene-1,3-indandione;2-(4-Dimethylaminobenzyliden)-indan-1,3-dion;N,N-dimethylaminobenzylidene 1,3-indandione;2-(4-(N,N-dimethylamino)benzylidene)-1H-indene-1,3(2H)-dione;2-(4-(dimethylamino)benzylidene)-2H-indene-1,3-dione;1,3-Indandione,2-(4-dimethylaminophenylmethylene);2-(4-Dimethylaminobenzylidene)-1,3-indandione;1,3-Indandione,2-(p-dimethylaminobenzylidene);2-(4-(Dimethylamino)benzylidene)-1H-indene-1,3(2H)-dione

Molecular Formula:C₁₈H₁₅NO₂

Molecular Weight:277.31700

HS Code:2922399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:492.3ºC at 760mmHg

Density:1.276g/cm3

Index of Refraction:1.696

PSA:37.38000

Exact Mass:277.11000

LogP:3.21520

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-((4-(DIMETHYLAMINO)PHENYL)METHYLENE)INDANE-1,3-DIONE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-(Dimethylamino)benzylidene)-1H-indene-1,3(2H)-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3-Indandione,2-(4-dimethylaminophenylmethylene) Use and application,2-((4-(DIMETHYLAMINO)PHENYL)METHYLENE)INDANE-1,3-DIONE technical grade,usp/ep/jp grade.

Related News: For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. diethyl 2-[4-imino-5-methyl-3-(4-methylbenzyloxy)-2-oxo-imidazolidin-5-yl]ethylphosphonate manufacturers The analysis examined disease manifestations in the two most commonly impacted organ domains in SLE. Anifrolumab is a potential first-in-class type I interferon inhibitor. 5-[1-(p-toluenesulfonyl)indol-4-yl]-methyl-2,4-thiazolidinedione suppliers The review by EMA’s safety committee (PRAC) supported by experts from the Committee for Advanced Therapies (CAT) found that the viral vector was unlikely to be the cause. Synthetase, solanesyl pyrophosphate (Rhodobacter capsulatum strainSB1003 gene sdsA) vendor & factory.